Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIMA: HBO2 for Persistent Post-Concussive Symptoms
NCT01611194Phase 2Completed
- Sponsor
- U.S. Army Medical Research and Development Command
- Start
- Sep 2012
- Primary completion
- Jan 2015
- Modality
- NPI (Non-Pharmacological Intervention)
- Countries
- 1
01
Overview
A Phase 2 trial of hyperbaric oxygen therapy in Post-concussion syndrome (PCS), sponsored by U.S. Army Medical Research and Development Command. Started Sep 2012; status: completed.
02
Drugs
hyperbaric oxygen therapy
03
Conditions
Post-concussion syndrome (PCS)
Beyond the preview
Go deeper on NCT01611194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01611194.